On-demand webinar reviewing the proposed changes to 21 C.F.R. Part 809 and their potential impact on labs.

The RCM landscape is poised for significant change as the healthcare industry continues to embrace new technologies.

The final pricing decision for a set of six new CPT codes covering genomic sequencing procedures has been delayed by the agency.

CY 2024 CMS payment guidelines, plus an extended telehealth reimbursement waiver

The FDA has proposed regulating laboratory-developed tests to align them with other in vitro diagnostics.